Skip to main content
. 2019 Nov 29;3:20. doi: 10.1186/s41824-019-0066-2

Fig. 47.

Fig. 47

68Ga-DOTA peptide, follow-up of NET, comparison 68Ga-DOTANOC, 68Ga-DOTATATE. Clinical history: 68 y.o. woman with midgut NET and liver metastases treated with octreotide. PET/CT findings: 68Ga-DOTANOC (a) and 68Ga-DOTATATE (b) performed 8 months apart show similar uptake in the metastatic lesions, but due to the higher liver 68Ga-DOTATATE uptake, more metastases are identified in the 68Ga-DOTANOC study